Wealth Enhancement Advisory Services, LLC Bio N Tech Se Put Options Transaction History
Wealth Enhancement Advisory Services, LLC
- $61.1 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BNTX
# of Institutions
312Shares Held
42.6MCall Options Held
1.27MPut Options Held
1.26M-
Baillie Gifford & CO7.88MShares$819 Million0.61% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$439 Million1.69% of portfolio
-
Primecap Management CO Pasadena, CA3.87MShares$402 Million0.3% of portfolio
-
Dodge & Cox San Francisco, CA3.65MShares$379 Million0.21% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.6MShares$374 Million0.24% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.2B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...